Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
4.800
+0.160 (3.45%)
May 29, 2026, 4:00 PM EDT - Market closed
MRVI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 204.73 | 185.74 | 259.19 | 288.95 | 883 | 799.24 | |
Revenue Growth (YoY) | -15.35% | -28.34% | -10.30% | -67.28% | 10.48% | 181.32% |
Cost of Revenue | 144.76 | 151.75 | 150.88 | 148.74 | 168.96 | 140.56 |
Gross Profit | 59.97 | 33.99 | 108.31 | 140.2 | 714.04 | 658.68 |
Selling, General & Admin | 134.65 | 145.12 | 161.77 | 151.39 | 129.26 | 100.06 |
Research & Development | 16.4 | 17.4 | 19.22 | 17.28 | 18.37 | 15.22 |
Other Operating Expenses | 77.18 | 86.74 | 162.93 | 3.18 | -7.8 | 11.25 |
Total Operating Expenses | 228.23 | 249.26 | 343.93 | 171.85 | 139.83 | 126.53 |
Operating Income | -168.26 | -215.27 | -235.62 | -31.65 | 574.22 | 554.65 |
Interest Income | 10.08 | 11.44 | 27.4 | 27.73 | 2.34 | - |
Interest Expense | -25.96 | -26.99 | -47.7 | -45.89 | -20.41 | -30.26 |
Other Non-Operating Income (Expense) | -4.67 | -4.15 | -5.57 | 667.55 | -4.67 | 6.38 |
Total Non-Operating Income (Expense) | -20.55 | -19.71 | -25.87 | 649.38 | -22.74 | -23.88 |
Pretax Income | -188.81 | -234.97 | -261.48 | 617.74 | 551.47 | 530.77 |
Provision for Income Taxes | -4.52 | -4.21 | -1.86 | 756.11 | 60.81 | 61.52 |
Net Income | -104.56 | -130.77 | -144.85 | -119.03 | 220.21 | 182.04 |
Minority Interest in Earnings | -79.73 | -99.99 | -114.78 | -19.35 | 270.46 | 287.21 |
Net Income to Common | -104.56 | -130.77 | -144.85 | -119.03 | 220.21 | 182.04 |
Net Income Growth | - | - | - | - | 20.97% | 104.60% |
Shares Outstanding (Basic) | 147 | 144 | 138 | 132 | 255 | 258 |
Shares Outstanding (Diluted) | 147 | 144 | 138 | 132 | 255 | 258 |
Shares Change (YoY) | 3.18% | 4.68% | 4.54% | -48.33% | -0.96% | - |
EPS (Basic) | -0.71 | -0.90 | -1.05 | -0.90 | 1.67 | 1.59 |
EPS (Diluted) | -0.71 | -0.90 | -1.05 | -0.90 | 1.67 | 1.56 |
EPS Growth | - | - | - | - | 7.05% | -33.90% |
Shares Outstanding | 147.5 | 145.32 | 141.98 | 132.23 | 131.69 | 131.49 |
Free Cash Flow | -28.3 | -69.99 | -15.05 | 73.54 | 519.99 | 353.72 |
Free Cash Flow Growth | - | - | - | -85.86% | 47.01% | 179.00% |
Free Cash Flow Per Share | -0.19 | -0.48 | -0.11 | 0.56 | 2.04 | 1.37 |
Gross Margin | 29.29% | 18.30% | 41.79% | 48.52% | 80.87% | 82.41% |
Operating Margin | -82.19% | -115.89% | -90.91% | -10.95% | 65.03% | 69.40% |
Profit Margin | -90.01% | -124.24% | -100.17% | -47.89% | 55.57% | 58.71% |
FCF Margin | -13.82% | -37.68% | -5.81% | 25.45% | 58.89% | 44.26% |
EBITDA | -109.72 | -154.79 | -178.75 | 17.13 | 612.32 | 588.19 |
EBITDA Margin | -53.59% | -83.34% | -68.97% | 5.93% | 69.35% | 73.59% |
EBIT | -168.26 | -215.27 | -235.62 | -31.65 | 574.22 | 554.65 |
EBIT Margin | -82.19% | -115.89% | -90.91% | -10.95% | 65.03% | 69.40% |
Effective Tax Rate | 2.39% | 1.79% | 0.71% | 122.40% | 11.03% | 11.59% |